Maximum home systolic blood pressure is a useful indicator of arterial stiffness in patients with type 2 diabetes mellitus: Post hoc analysis of a cross-sectional multicenter study

被引:14
|
作者
Ushigome, Emi [1 ]
Fukui, Michiaki [1 ]
Hamaguchi, Masahide [2 ]
Tanaka, Toru [3 ]
Atsuta, Haruhiko [4 ]
Mogami, Shin-ichi [5 ]
Tsunoda, Sei [6 ]
Yamazaki, Masahiro [1 ]
Hasegawa, Goji [1 ]
Nakamura, Naoto [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto 6028566, Japan
[2] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan
[3] Kyoto First Red Cross Hosp, Dept Endocrinol & Metab, Kyoto, Japan
[4] Kyoto Second Red Cross Hosp, Dept Endocrinol & Metab, Kyoto, Japan
[5] West Japan Railway Co, Osaka Gen Hosp, Dept Endocrinol & Metab, Osaka, Japan
[6] Nishijin Hosp, Dept Cardiol, Kyoto, Japan
关键词
Home blood pressure monitoring; Maximum home systolic blood pressure; Multicenter study; PULSE-WAVE VELOCITY; CARDIOVASCULAR RISK; HEART-RATE; VARIABILITY; PREDICTOR; POPULATION; PROGNOSIS; SOCIETY; DAMAGE;
D O I
10.1016/j.diabres.2014.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Maximum (max) home systolic blood pressure (HSBP) as well as mean HSBP or HSBP variability was reported to increase the predictive value of target organ damage. Yet, the association between max HSBP and target organ damage in patients with type 2 diabetes has never been reported. The aim of this study was to investigate the association between max HSBP and pulse wave velocity (PWV), a marker of arterial stiffness which in turn is a marker of target organ damage, in patients with type 2 diabetes. Methods: We assessed the relationship of mean HSBP or max HSBP to PWV, and compared area under the receiver-operating characteristic curve (AUC) of mean HSBP or max HSBP for arterial stiffness in 758 patients with type 2 diabetes. Results: In the univariate analyses, age, duration of diabetes mellitus, body mass index, mean clinic systolic blood pressure (SBP), mean HSBP and max HSBP were associated with PWV. Multivariate linear regression analyses indicated that mean morning SBP (beta = 0.156, P = 0.001) or max morning SBP (beta = 0.146, P = 0.001) were significantly associated with PWV. AUC (95% CI) for arterial stiffness, defined as PWV equal to or more than 1800 cm per second, in mean morning SBP and max morning SBP were 0.622 (0.582-0.662; P < 0.001) and 0.631 (0.591-0.670; P < 0.001), respectively. Conclusions: Our findings implicate that max HSBP as well as mean HSBP was significantly associated with arterial stiffness in patients with type 2 diabetes. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:344 / 351
页数:8
相关论文
共 50 条
  • [41] The Association of Blood Glucose Levels and Arterial Stiffness (Cardio-Ankle Vascular Index) in Patients With Type 2 Diabetes Mellitus
    Alghamdi, Yazid A.
    Al-Shahrani, Faisal S.
    Alanazi, Saif S.
    Alshammari, Fahad A.
    Alkhudair, Abdullah M.
    Jatoi, Noor-Ahmed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [42] Alexithymia as a risk factor for type 2 diabetes mellitus in the metabolic syndrome: a cross-sectional study
    Lemche, Alexandra V.
    Chaban, Oleg S.
    Lemche, Erwin
    PSYCHIATRY RESEARCH, 2014, 215 (02) : 438 - 443
  • [43] Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with type 2 diabetes mellitus
    Kitagawa, Nobuko
    Ushigome, Emi
    Kitagawa, Noriyuki
    Ushigome, Hidetaka
    Yokota, Isao
    Nakanishi, Naoko
    Hamaguchi, Masahide
    Asano, Mai
    Yamazaki, Masahiro
    Fukui, Michiaki
    DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (03)
  • [44] Threshold value of home pulse pressure predicting arterial stiffness in patients with type 2 diabetes: KAMOGAWA-HBP study
    Kitagawa, Noriyuki
    Ushigome, Emi
    Matsumoto, Shinobu
    Oyabu, Chikako
    Ushigome, Hidetaka
    Yokota, Isao
    Asano, Mai
    Tanaka, Muhei
    Yamazaki, Masahiro
    Fukui, Michiaki
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (03) : 472 - 477
  • [45] Visceral fat might impact left ventricular remodeling through changes in arterial stiffness in type 2 diabetes: A cross-sectional study
    Huang, Haishan
    Jin, Jing
    Chen, Yanshan
    Wang, Lina
    Zhong, Jingyi
    Chen, Zhenguo
    Xu, Lingling
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 368 : 78 - 84
  • [46] Systolic inter-arm blood pressure difference and estimated glomerular filtration rate in type 2 diabetic patients in Palestine: a cross-sectional study
    Sweity, Raghad
    Fanoun, Khadeeja
    Jarrar, Tareq
    Alqtishat, Bayan F.
    Abdelhafez, Mohammad
    Ereqat, Suheir
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [47] Comparison of perioperative glucose regulation in patients with type 1 vs type 2 diabetes mellitus: A retrospective cross-sectional study
    Hulst, Abraham H.
    Polderman, Jorinde A. W.
    Kooij, Fabian O.
    Vittali, Dave
    Lirk, Philipp
    Hollmann, Markus W.
    DeVries, J. Hans
    Preckel, Benedikt
    Hermanides, Jeroen
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2019, 63 (03) : 314 - 321
  • [48] Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?
    Bouchi, Ryotaro
    Ohara, Norihiko
    Asakawa, Masahiro
    Nakano, Yujiro
    Takeuchi, Takato
    Murakami, Masanori
    Sasahara, Yuriko
    Numasawa, Mitsuyuki
    Minami, Isao
    Izumiyama, Hajime
    Hashimoto, Koshi
    Yoshimoto, Takanobu
    Ogawa, Yoshihiro
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [49] Estimates of arterial stiffness and central blood pressure in patients with type 2 diabetes: A comparison of SphygmoCor and Arteriograph
    Krogager, Christoffer
    Rossen, Niklas B.
    Hansen, Klavs W.
    Knudsen, Soren T.
    Peters, Christian D.
    Botker, Hans Erik
    Poulsen, Per L.
    Laugesen, Esben
    ARTERY RESEARCH, 2016, 16 : 18 - 24
  • [50] Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
    Chilton, R.
    Tikkanen, I.
    Cannon, C. P.
    Crowe, S.
    Woerle, H. J.
    Broedl, U. C.
    Johansen, O. E.
    DIABETES OBESITY & METABOLISM, 2015, 17 (12) : 1180 - 1193